abrdn Life Sciences Investors (HQL) Competitors $14.24 +0.01 (+0.04%) Closing price 09/9/2025 03:58 PM EasternExtended Trading$14.26 +0.03 (+0.18%) As of 09/9/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HQL vs. CET, GSBD, MFIC, NMFC, BBDC, BCSF, PFLT, AWF, HQH, and PHKShould you be buying abrdn Life Sciences Investors stock or one of its competitors? The main competitors of abrdn Life Sciences Investors include Central Securities (CET), Goldman Sachs BDC (GSBD), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), Barings Bdc (BBDC), Bain Capital Specialty Finance (BCSF), PennantPark Floating Rate Capital (PFLT), AllianceBernstein Global High Income Fund (AWF), abrdn Healthcare Investors (HQH), and PIMCO High Income Fund (PHK). These companies are all part of the "financial services" industry. abrdn Life Sciences Investors vs. Its Competitors Central Securities Goldman Sachs BDC MidCap Financial Investment New Mountain Finance Barings Bdc Bain Capital Specialty Finance PennantPark Floating Rate Capital AllianceBernstein Global High Income Fund abrdn Healthcare Investors PIMCO High Income Fund abrdn Life Sciences Investors (NYSE:HQL) and Central Securities (NYSE:CET) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations. Which has more risk and volatility, HQL or CET? abrdn Life Sciences Investors has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Central Securities has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Does the media favor HQL or CET? In the previous week, abrdn Life Sciences Investors had 5 more articles in the media than Central Securities. MarketBeat recorded 8 mentions for abrdn Life Sciences Investors and 3 mentions for Central Securities. Central Securities' average media sentiment score of 1.61 beat abrdn Life Sciences Investors' score of 1.00 indicating that Central Securities is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Life Sciences Investors 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Central Securities 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation & earnings, HQL or CET? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioabrdn Life Sciences InvestorsN/AN/AN/AN/AN/ACentral Securities$222.17M6.54N/AN/AN/A Is HQL or CET more profitable? Company Net Margins Return on Equity Return on Assets abrdn Life Sciences InvestorsN/A N/A N/A Central Securities N/A N/A N/A Is HQL or CET a better dividend stock? abrdn Life Sciences Investors pays an annual dividend of $1.40 per share and has a dividend yield of 9.8%. Central Securities pays an annual dividend of $2.30 per share and has a dividend yield of 4.6%. Do insiders & institutionals believe in HQL or CET? 32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. Comparatively, 8.7% of Central Securities shares are owned by institutional investors. 10.1% of abrdn Life Sciences Investors shares are owned by company insiders. Comparatively, 9.5% of Central Securities shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Summaryabrdn Life Sciences Investors beats Central Securities on 4 of the 7 factors compared between the two stocks. Get abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricabrdn Life Sciences InvestorsFIN IndustryFinance SectorNYSE ExchangeMarket Cap$410.85M$3.96B$12.63B$21.32BDividend Yield9.84%6.15%5.40%3.49%P/E RatioN/AN/A232.2929.42Price / SalesN/A33.6430.9168.57Price / CashN/A18.0522.1224.61Price / BookN/A1.212.294.55Net IncomeN/A$161.89M$1.01B$999.91M7 Day Performance0.81%1.62%0.98%0.93%1 Month Performance7.60%2.87%3.88%5.24%1 Year Performance-5.10%3.36%543.18%16.56% abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLabrdn Life Sciences InvestorsN/A$14.24+0.0%N/A-4.5%$410.85MN/A0.00N/APositive NewsShort Interest ↓CETCentral SecuritiesN/A$49.99+0.0%N/A+13.3%$1.45B$222.17M0.006Positive NewsGSBDGoldman Sachs BDC1.1953 of 5 stars$11.45+0.2%$10.00-12.6%-17.8%$1.31B$434.37M9.08N/AMFICMidCap Financial Investment2.5289 of 5 stars$13.22+0.1%$13.30+0.6%-10.1%$1.23B$301.78M12.24N/APositive NewsGap DownNMFCNew Mountain Finance2.9757 of 5 stars$10.66+1.1%$10.75+0.8%-13.3%$1.13B$371.67M14.03N/ANews CoveragePositive NewsBBDCBarings Bdc2.0314 of 5 stars$9.91+0.6%$9.67-2.4%-2.9%$1.04B$286.17M10.3226News CoverageBCSFBain Capital Specialty Finance2.444 of 5 stars$15.81+1.0%$16.50+4.4%-7.0%$1.03B$292.65M9.521,000News CoveragePositive NewsPFLTPennantPark Floating Rate Capital3.1111 of 5 stars$10.26+0.7%$10.88+6.0%-10.7%$1.02B$89.89M7.33658Dividend AnnouncementShort Interest ↑AWFAllianceBernstein Global High Income FundN/A$11.290.0%N/A+1.2%$972.67MN/A0.00N/AHQHabrdn Healthcare InvestorsN/A$16.52+0.9%N/A-9.5%$890.88MN/A0.00147,000News CoveragePositive NewsShort Interest ↓PHKPIMCO High Income FundN/A$4.96+0.5%N/A+1.4%$850.60MN/A0.00147,000 Related Companies and Tools Related Companies CET Competitors GSBD Competitors MFIC Competitors NMFC Competitors BBDC Competitors BCSF Competitors PFLT Competitors AWF Competitors HQH Competitors PHK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HQL) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HQL Stock Alerts